AbbVie, earnings day
AbbVie slips 3.2% in earnings week as sellers take over the last session
AbbVie, earnings day
Our view last week
AbbVie shares close the week up 1.9% and stay within a whisker of their all-time highs, just 0.88% away. It's a level already tested 4 times over the past 10 weeks: a crowded wall, not open sky, which is why entry today only makes sense on a pullback. Earnings land this very week, on July 31, an active risk factor to watch. The buy signal is in its 8th week, and the trade is up 19.13% since entry.
This week's summary
AbbVie closes the week down 3.2%, a clear change of pace after brushing all-time highs seven days ago. The last session saw sellers clearly in control, and daily cash flow slipped into negative territory: two short-term caution flags. Earnings land today, an active risk factor for anyone eyeing a fresh entry. The buy signal is in its 9th week, and the trade is up 15.26% since entry.
IQS Phase
51
ordinary
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#25 / 120
US stocks in progress
Trade P&L %
+15.26%
from signal to date, no stop loss
Rank position
ranks 25th among the 120 Longs already running for US stocks in our ranking, with a signal strength of 66 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
ABBV belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content